newsfilter
← Latest News
GlobeNewswire·

Entrada Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference

BOSTON, June 03, 2024 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (NASDAQ:TRDA) is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that